Medical management of benign prostatic hyperplasia in older adults

David F. Mobley, Neil Baum

Research output: Contribution to journalReview articlepeer-review


Benign Prostatic Hyperplasia (BPH) is a pervasive condition associated with the aging process. Causes of BPH include stimulation of the alpha receptors located in the prostate gland and bladder neck, or an increase in epithelial cell proliferation, resulting in enlargement of the prostate gland and subsequent passive compression of the uretha. Medical treatment consists of alpha-blockers or 5-alpha-reductase inhibition. This article will review the evaluation and the medical treatment for patients with mild to moderate BPH and provide suggestions for urologic referral.

Original languageEnglish (US)
Pages (from-to)23-28
Number of pages6
JournalGeriatrics and Aging
Issue number6
StatePublished - Jun 1 2004


  • 5-alpha-reductase inhibitors
  • Alpha blockers
  • BPH
  • Prostate
  • PSA

ASJC Scopus subject areas

  • Geriatrics and Gerontology


Dive into the research topics of 'Medical management of benign prostatic hyperplasia in older adults'. Together they form a unique fingerprint.

Cite this